HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

28-O-caffeoyl betulin

Neuroprotective Agent; structure in first source

Also Known As:

B-CA compound

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - Pentacyclic Triterpenes: 108
        Lupanes: 28
        Betulinic Acid: 545
        28-O-caffeoyl betulin: 2
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Cinnamates: 48
      - Caffeic Acids: 15
        28-O-caffeoyl betulin: 2

Experts

1.	Ruan, Zhi: 2 articles (03/2021 - 04/2015)
2.	Wu, Lei: 2 articles (03/2021 - 04/2015)
3.	Feng, Hong-Xuan: 1 article (03/2021)
4.	Liu, Xia: 1 article (03/2021)
5.	Mu, Hong-Yan: 1 article (03/2021)
6.	Shao, Xing-Cheng: 1 article (03/2021)
7.	Wang, Hong-Min: 1 article (03/2021)
8.	Wang, Wei: 1 article (03/2021)
9.	Zhang, Hai-Yan: 1 article (03/2021)
10.	Zhang, Nai-Xia: 1 article (03/2021)

Related Diseases

1.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/01/2021 - "28-O-caffeoyl betulin (B-CA) has been demonstrated to reduce the cerebral infarct volume caused by transient middle cerebral artery occlusion (MCAO) injury. " 04/01/2015 - "Here, we provide the first demonstration that 28-O-caffeoyl betulin (B-CA), a novel derivative of naturally occurring caffeoyl triterpene, could significantly alleviate brain infarction and neurological deficit when given as late as 6 h after transient middle cerebral artery occlusion in the rat. "
2.	Brain Infarction 04/01/2015 - "Here, we provide the first demonstration that 28-O-caffeoyl betulin (B-CA), a novel derivative of naturally occurring caffeoyl triterpene, could significantly alleviate brain infarction and neurological deficit when given as late as 6 h after transient middle cerebral artery occlusion in the rat. "
3.	Cerebral Infarction 03/01/2021 - "28-O-caffeoyl betulin (B-CA) has been demonstrated to reduce the cerebral infarct volume caused by transient middle cerebral artery occlusion (MCAO) injury. "

Related Drugs and Biologics

1.	Triterpenes
2.	4-O-carboxymethylascochlorin